Asset Manager

Updated:

Aspirion Health Resources

Aspirion Health Resources is a healthcare receivables investor providing liquidity to hospitals against complex, denied insurance claims.

Aspirion Health Resources

Aspirion occupies a narrow, high-expertise niche within healthcare finance. The firm partners with hospitals and large physician groups to resolve complex claims—typically motor vehicle accident liens, workers' compensation denials, and VA/Tricare underpayments—that fall outside standard billing cycles. Rather than operate as a traditional revenue cycle vendor billing on contingency, Aspirion functions as a principal, buying or lending against those receivables. That balance-sheet commitment separates it from the dozens of outsourced RCM shops that simply process claims for a fee. The firm's strategy bridges private credit and distressed healthcare receivables. Its capital goes to work not through equity buyouts but through structured advances and receivables purchases, often on a non-recourse basis once the underlying adjudication risk is sized. The asset mix spans hospital account purchases, legal claim recoveries, and credit-intermediation to providers navigating the administrative state. While the firm does not publicly name its limited partners or credit facilities, its Columbus base places it in proximity to a deep regional insurance and healthcare-operations talent pool, drawing from organizations like Nationwide and Cardinal Health. Because Aspirion does not publish team size, deployment volumes, or fund structures, its scale can only be inferred from execution speed and market footprint. Competing entities in this space include Healthcare Funding Solutions and Advocate Capital, but Aspirion's focus on the institutional hospital market signals a mid-market credit vehicle rather than a plaintiff-firm factoring shop. Its adjacent relationship structures likely include forward-flow purchase agreements with health systems and revolving credit lines from specialty-finance banks, though exact arrangements remain undisclosed. The structural differentiator is Aspirion's dual competency in revenue-cycle operations and principal investing. Most financial sponsors lack the in-house legal and medical-coding infrastructure to underwrite a denied cardiac-surgery claim against an out-of-state auto insurer; Aspirion exists to do precisely that, using data-extraction technology and a staff of clinicians, attorneys, and coders to price the recovery probability. No public record indicates the firm has evolved into a multi-family office or philanthropic vehicle. It remains a dedicated, capital-intensive healthcare services business.

General information

Firm type

Asset Manager

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Columbus

Corporate office

Columbus, OH, United States

Sector focus

Healthcare ServicesPrivate Credit

Frequently asked questions

What exactly does Aspirion Health Resources invest in?

Aspirion deploys capital into complex healthcare accounts receivable. It buys or lends against claims that have been denied or underpaid by commercial insurers, government payers, or third-party liability carriers—especially workers' compensation and motor vehicle accident claims. This is a form of specialty finance, not corporate lending or private equity.

How does Aspirion differ from a traditional hospital revenue cycle vendor?

Most revenue cycle management firms charge a contingency fee for recovery services without putting their own capital at risk upfront. Aspirion operates as a principal, using its balance sheet to purchase receivables or provide advances before recovery. That capital commitment defines the firm as an investor rather than a pure service provider.

Who are Aspirion's counterparties?

The firm works primarily with hospitals and large health systems, not individual patients. Its counterparties are institutions with volumes of complex, high-dollar claims that fall outside standard first-pass billing automation—trauma centers, academic medical centers, and regional health networks with substantial workers' comp and auto-accident caseloads.

What risk factors are inherent in the firm's strategy?

The key risk is regulatory and reimbursement policy change. Shifts in state workers' compensation laws, federal VA/Tricare payment rules, or commercial insurer adjudication algorithms can alter recovery rates on purchased claims. Operational risk also concentrates in the firm's ability to retain the specialized legal and clinical staff needed to underwrite and recover effectively.

Has Aspirion disclosed any institutional fund structures?

No. Aspirion has not publicly disclosed a commingled fund structure, close date, or limited partner base as of the latest available records. Its capital deployment model appears to rely on proprietary credit facilities and health-system direct relationships, keeping it off the radar of most institutional fund databases.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Columbus Asset Manager profiles